Drug recall · May 15, 2013
QUELICIN recall
Why: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02
- Lots / codes
Lot 21-480-EV Exp.12/13
- Quantity
- 139,200 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- February 26, 2013 · Voluntary: Firm initiated
- Classified
- May 6, 2013
- Reported
- May 15, 2013
- Ended
- November 10, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Succinylcholine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.